370 related articles for article (PubMed ID: 21690492)
41. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
42. [Cerebral embolism in systemic lupus erythematosus with Libman-Sacks endocarditis: a case report].
Kasuya J; Hashimoto Y; Terasaki T; Shimamura M; Uchino M
Rinsho Shinkeigaku; 2000 Jul; 40(7):707-11. PubMed ID: 11186909
[TBL] [Abstract][Full Text] [Related]
43. Catastrophic anti-phospholipid syndrome in the absence of IgG anti-cardiolipin antibodies.
Kennedy M; Jackson J; Khan I; Keeling PW; Gaffney E
Scand J Rheumatol; 1995; 24(6):389-91. PubMed ID: 8610226
[TBL] [Abstract][Full Text] [Related]
44. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
45. Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus.
Balada E; Ordi-Ros J; Paredes F; Villarreal J; Mauri M; Vilardell-Tarrés M
Scand J Rheumatol; 2001; 30(4):235-41. PubMed ID: 11578020
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study.
Metz D; Jolly D; Graciet-Richard J; Nazeyrollas P; Chabert JP; Maillier B; Pennaforte JL; Elaerts J
Cardiology; 1994; 85(2):129-36. PubMed ID: 7954564
[TBL] [Abstract][Full Text] [Related]
47. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
[TBL] [Abstract][Full Text] [Related]
48. Valvular heart disease in antiphospholipid syndrome.
Zuily S; Huttin O; Mohamed S; Marie PY; Selton-Suty C; Wahl D
Curr Rheumatol Rep; 2013 Apr; 15(4):320. PubMed ID: 23456852
[TBL] [Abstract][Full Text] [Related]
49. [Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies].
Lolli C; Foscoli M; Giofrè R; Tarquinii M; Pasquali S; Toschi GP
G Ital Cardiol; 1993 Nov; 23(11):1125-34. PubMed ID: 8163102
[TBL] [Abstract][Full Text] [Related]
50. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
51. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
52. Libman-Sacks Endocarditis Due to Systemic Lupus Erythematosus Activation After Mitral Valve Plasty.
Samura T; Toda K; Yoshioka D; Nakamura T; Miyagawa S; Yoshikawa Y; Saito S; Domae K; Sawa Y
Ann Thorac Surg; 2017 Aug; 104(2):e109-e111. PubMed ID: 28734427
[TBL] [Abstract][Full Text] [Related]
53. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
[TBL] [Abstract][Full Text] [Related]
54. Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients.
Gkrouzman E; Peng M; Davis-Porada J; Kirou KA
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):656-664. PubMed ID: 33171010
[TBL] [Abstract][Full Text] [Related]
55. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
[TBL] [Abstract][Full Text] [Related]
56. Libman-Sacks endocarditis and cerebral embolization in antiphospholipid syndrome.
Lønnebakken MT; Gerdts E
Eur J Echocardiogr; 2008 Jan; 9(1):192-3. PubMed ID: 18267921
[TBL] [Abstract][Full Text] [Related]
57. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis.
Roldan CA
Minerva Cardioangiol; 2009 Aug; 57(4):467-81. PubMed ID: 19763069
[TBL] [Abstract][Full Text] [Related]
59. [Heart valve involvement in systemic lupus erythematosus: an echocardiographic study].
Marcon C; Moro E; Sforza P; Piccoli G; Maresca MC; Adami A
G Ital Cardiol; 1992 Nov; 22(11):1301-8. PubMed ID: 1297616
[TBL] [Abstract][Full Text] [Related]
60. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
